Blue Owl Capital Holdings Lp Top Holdings and 13F Report (2025) About Blue Owl Capital Holdings LpInvestment ActivityBlue Owl Capital Holdings Lp has $310.08 million in total holdings as of March 31, 2025.Blue Owl Capital Holdings Lp owns shares of 73 different stocks, but just 16 companies or ETFs make up 80% of its holdings.Approximately 13.61% of the portfolio was purchased this quarter.About 21.17% of the portfolio was sold this quarter.This quarter, Blue Owl Capital Holdings Lp has purchased 78 new stocks and bought additional shares in 18 stocks.Blue Owl Capital Holdings Lp sold shares of 4 stocks and completely divested from 16 stocks this quarter.Largest Holdings NUVEEN CHURCHILL DIRECT LEND $68,591,610Blue Owl Capital $29,980,726Cullinan Therapeutics $18,440,308EverCommerce $16,550,645TOURMALINE BIO INC $15,774,397 Largest New Holdings this Quarter 74347X831 - ProShares UltraPro QQQ $10,027,500 Holding17878Y207 - Civeo $8,009,198 Holding603170101 - Mineralys Therapeutics $3,275,980 Holding65345N106 - NextNav $2,418,909 Holding925050106 - Verona Pharma $1,164,851 Holding Largest Purchases this Quarter ProShares UltraPro QQQ 175,000 shares (about $10.03M)Civeo 348,226 shares (about $8.01M)Holley 2,327,746 shares (about $5.98M)Mineralys Therapeutics 206,296 shares (about $3.28M)COMPASS Pathways 974,590 shares (about $2.79M) Largest Sales this Quarter PALVELLA THERAPEUTICS INC 109,803 shares (about $3.07M)GoHealth 58,168 shares (about $1.61M)TOURMALINE BIO INC 42,214 shares (about $642.07K)Eledon Pharmaceuticals 140,000 shares (about $474.60K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBlue Owl Capital Holdings Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNUVEEN CHURCHILL DIRECT LEND$68,591,6100.0%4,039,55322.1%COM SHSOBDCBlue Owl Capital$29,980,7260.0%2,045,0709.7%FinanceCGEMCullinan Therapeutics$18,440,308$492,050 ▲2.7%2,435,9725.9%MedicalEVCMEverCommerce$16,550,6450.0%1,641,9295.3%Computer and TechnologyTOURMALINE BIO INC$15,774,397$642,075 ▼-3.9%1,037,1075.1%COMCNDTConduent$15,383,115$194,376 ▲1.3%5,697,4505.0%Business ServicesENGENE HOLDINGS INC$14,691,613$534,925 ▲3.8%3,279,3784.7%COMHLLYHolley$13,667,363$5,982,307 ▲77.8%5,318,0404.4%Auto/Tires/TrucksLRMRLarimar Therapeutics$10,272,786$268,750 ▲2.7%4,778,0403.3%MedicalTQQQProShares UltraPro QQQ$10,027,500$10,027,500 ▲New Holding175,0003.2%ETFCVEOCiveo$8,009,198$8,009,198 ▲New Holding348,2262.6%Consumer DiscretionaryIRONDisc Medicine$6,962,506$992,800 ▲16.6%140,2602.2%MedicalELDNEledon Pharmaceuticals$6,169,502$474,600 ▼-7.1%1,819,9122.0%MedicalCMPXCompass Therapeutics$5,613,9530.0%2,954,7121.8%MedicalRAREUltragenyx Pharmaceutical$5,548,748$1,267,350 ▲29.6%153,2381.8%MedicalIKNAIkena Oncology$5,236,6310.0%4,091,1181.7%MedicalCNTACentessa Pharmaceuticals$4,529,700$1,366,100 ▲43.2%315,0001.5%MedicalCNTXContext Therapeutics$4,509,158$618,106 ▲15.9%7,367,9061.5%MedicalSAGIMET BIOSCIENCES INC$4,330,424$14,585 ▲0.3%1,328,3511.4%COM SER AEYPTEyePoint Pharmaceuticals$4,322,959$704,600 ▲19.5%797,5941.4%MedicalPLRXPliant Therapeutics$4,008,419$270,000 ▲7.2%2,969,1991.3%MedicalPALVELLA THERAPEUTICS INC$3,925,849$3,073,386 ▼-43.9%140,2591.3%COMRPTXRepare Therapeutics$3,395,1030.0%3,443,6591.1%MedicalETWOE2open Parent$3,301,8860.0%1,650,9431.1%Computer and TechnologyMLYSMineralys Therapeutics$3,275,980$3,275,980 ▲New Holding206,2961.1%MedicalCMPSCOMPASS Pathways$3,248,468$2,787,327 ▲604.4%1,135,8281.0%MedicalTNGXTango Therapeutics$2,906,663$533,615 ▲22.5%2,121,6520.9%MedicalKROSKeros Therapeutics$2,710,876$238,446 ▲9.6%266,0330.9%MedicalAQSTAquestive Therapeutics$2,668,000$58,000 ▲2.2%920,0000.9%MedicalNNNextNav$2,418,909$2,418,909 ▲New Holding198,7600.8%Business ServicesGATEMarblegate Acquisition$1,371,5860.0%91,4290.4%Financial ServicesVRNAVerona Pharma$1,164,851$1,164,851 ▲New Holding18,3470.4%MedicalEPDEnterprise Products Partners$1,068,2410.0%31,2900.3%EnergyADCTADC Therapeutics$1,034,3310.0%733,5680.3%MedicalINZYInozyme Pharma$982,8250.0%1,080,0270.3%MedicalGOCOGoHealth$694,352$1,609,383 ▼-69.9%25,0960.2%FinanceMRKRMarker Therapeutics$681,7280.0%554,2500.2%MedicalALPHA MODUS HLDGS INC$454,191$454,191 ▲New Holding394,0780.1%CL AROIVRoivant Sciences$393,5400.0%39,0030.1%MedicalSHF HOLDINGS INC$325,598$325,598 ▲New Holding75,8970.1%CL A NEWCAHCardinal Health$236,6890.0%1,7180.1%MedicalREZOLVE AI LTD$219,8170.0%181,6670.1%ORD SHSSOUTHLAND HLDGS INC$137,6480.0%860,3020.0%*W EXP 02/14/202NIOBWNioCorp Developments$122,6440.0%766,5270.0%Basic MaterialsREZOLVE AI LTD$120,6860.0%603,4290.0%*W EXP 08/15/202ALPHA MODUS HLDGS INC$106,421$38,253 ▲56.1%1,854,6650.0%*W EXP 12/13/202GATEWMarblegate Acquisition$95,5730.0%597,3330.0%Financial ServicesCRITICAL METALS CORP$94,128$94,128 ▲New Holding67,7180.0%PUBCO ORD SHSBLACKSKY TECHNOLOGY INC$45,5000.0%350,0000.0%*W EXP 09/09/202SYNTEC OPTICS HLDGS INC$40,1570.0%803,1320.0%*W EXP 99/99/999BRAND ENGAGEMENT NETWORK INC$33,336$32,650 ▲4,759.1%1,666,8080.0%*W EXP 03/14/202AEON BIOPHARMA INC$24,565$24,565 ▲New Holding42,3530.0%CL A NEWENGENE HOLDINGS INC$21,6740.0%36,1000.0%*W EXP 10/31/202ZAPPWZapp Electric Vehicles Group$19,3100.0%1,930,9860.0%Consumer CyclicalZEO ENERGY CORP$15,0000.0%250,0000.0%*W EXP 03/13/202ROADZEN INC$13,5000.0%225,0000.0%*W EXP 11/30/202TEVOGEN BIO HLDGS INC$10,0000.0%200,0000.0%*W EXP 02/14/202HERAMBA ELEC PLC$9,9000.0%989,9980.0%*W EXP 07/26/202BAIRD MED INVT HLDGS LTD$8,0000.0%100,0000.0%*W EXP 10/01/202LIVEWIRE GROUP INC$8,0000.0%400,0000.0%*W EXP 09/26/202PGYWWPagaya Technologies$6,8130.0%48,6610.0%Computer and TechnologyNVNI GROUP LIMITED$6,0000.0%200,0000.0%*W EXP 11/01/202VAST RENEWABLES LIMITED$6,0000.0%200,0000.0%*W EXP 07/01/202DAVEWDave$5,1750.0%28,7500.0%Computer and TechnologyBOLT PROJS HLDGS INC$5,000$5,000 ▲New Holding166,6660.0%*W EXP 08/13/202WALDWWaldencast$4,3330.0%33,3330.0%Computer and TechnologyKPLTWKatapult$4,0000.0%400,0000.0%Computer and TechnologyBTMWWBitcoin Depot$4,0000.0%50,0000.0%Financial ServicesASPIRE BIOPHARMA HLDGS INC$3,500$3,500 ▲New Holding50,0000.0%*W EXP 02/14/203ZOOMCAR HLDGS INC$2,5000.0%250,0000.0%*W EXP 05/31/202PBAXWPhoenix Biotech Acquisition$2,2490.0%224,9300.0%Financial ServicesSTARDUST PWR INC$1,1670.0%16,6660.0%*W EXP 06/21/202XBP EUROPE HOLDINGS INC$7430.0%24,7780.0%*W EXP 11/30/202KLAVIYO INC$0$44,488,475 ▼-100.0%00.0%COM SER ASLRNAcelyrin$0$8,741,590 ▼-100.0%00.0%MedicalMREOMereo BioPharma Group$0$2,354,832 ▼-100.0%00.0%MedicalAEON BIOPHARMA INC$0$1,646,655 ▼-100.0%00.0%CL AOMGAOmega Therapeutics$0$787,266 ▼-100.0%00.0%MedicalSHFSSHF$0$683,066 ▼-100.0%00.0%FinanceGTLBGitLab$0$567,782 ▼-100.0%00.0%Computer and TechnologyAPTMWPlum Acquisition Corp. III$0$220,000 ▼-100.0%00.0%Financial ServicesSYNTEC OPTICS HLDGS INC$0$124,929 ▼-100.0%00.0%CL AAPTMUAlpha Partners Technology Merger$0$94,573 ▼-100.0%00.0%Financial ServicesSATXSatixfy Communications$0$77,715 ▼-100.0%00.0%Computer and TechnologyBTMBitcoin Depot$0$25,718 ▼-100.0%00.0%FinanceBYNOWbyNordic Acquisition$0$20,647 ▼-100.0%00.0%Financial ServicesNKGEN BIOTECH INC$0$3,000 ▼-100.0%00.0%*W EXP 05/31/202PWUPWPowerUp Acquisition$0$2,500 ▼-100.0%00.0%Financial ServicesBYNObyNordic Acquisition$0$549 ▼-100.0%00.0%Financial ServicesShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
